Targeted Medical Pharma, Inc.
TRGM · OTC
12/31/2015 | 9/30/2015 | 6/30/2015 | 3/31/2015 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $83 | $21 | $21 | $223 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $467 | $273 | $182 | $159 |
| Inventory | $92 | $124 | $125 | $85 |
| Other Curr. Assets | $0 | $243 | $229 | $430 |
| Total Curr. Assets | $833 | $660 | $557 | $898 |
| Property Plant & Equip (Net) | $54 | $68 | $79 | $91 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $1,540 | $1,721 | $1,762 | $1,811 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1,594 | $1,789 | $1,841 | $1,903 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,427 | $2,449 | $2,398 | $2,800 |
| Liabilities | – | – | – | – |
| Payables | $1,864 | $1,982 | $1,926 | $2,114 |
| Short-Term Debt | $4,624 | $4,407 | $3,980 | $4,262 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3,874 | $3,801 | $46 | $3,612 |
| Total Curr. Liab. | $14,675 | $13,968 | $13,221 | $13,328 |
| LT Debt | $671 | $815 | $1,289 | $1,093 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $671 | $815 | $1,289 | $1,093 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $15,346 | $14,783 | $14,510 | $14,421 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $28 | $28 | $27 | $27 |
| Retained Earnings | -$29,961 | -$29,380 | -$29,142 | -$28,596 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$12,895 | -$12,334 | -$12,112 | -$11,620 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$23 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,427 | $2,449 | $2,398 | $2,800 |
| Net Debt | $5,212 | $5,202 | $5,247 | $5,131 |